MECHANOSTICS
LIVE

Serial Number

98679322

Owner

PRECISIONLIFE LTD.

Attorney

Geza C. Ziegler Jr.

Filing Date

Aug 2, 2024

Add to watchlist:

No watchlists yet
View on USPTO

MECHANOSTICS Trademark

Serial Number: 98679322

MECHANOSTICS is a trademark filed by PRECISIONLIFE LTD. on August 2, 2024. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

PRECISIONLIFE LTD.

Long Hanborough
Witney OX298LJ , GB

Entity Type: 99

Trademark Details

Filing Date

August 2, 2024

Registration Date

Not Registered

Published for Opposition

February 24, 2026

Goods & Services

Medical diagnostic apparatus for detecting biomarkers; Apparatus for blood analysis.

Data processing services in the field of healthcare; business administration services in the field of healthcare

Healthcare; Healthcare consultancy; healthcare services; Providing healthcare information; healthcare advisory services in the field of medical treatment, wellness, nutrition; clinical health counselling services; medical health assessment services; medical and healthcare services in the fields of DNA, genetics and genetic testing; genetic testing for medical purposes; healthcare services, namely, monitoring of patients with disorders; individual medical counseling services provided to patients; medical care and analysis services relating to treatment of patients with conditions, namely, cancer, diabetes, and bipolar disorder; health counseling; health screening in the fields of oncology, neuropsychiatric and metabolic disease; providing news and information in the field of medicine

Scientific research; clinical research in the field of medicine, healthcare, genetics, nutrition, phenotypic, dietary, wellness, breast cancer, ontologies; Scientific research in the nature of conducting clinical trials for others; biological research; medical research; providing information about scientific clinical studies via an interactive website; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research in the field of gene therapy; genetic engineering services, namely, scientific research in the field of genetic engineering; human biomedical genetic research; scientific research in the field of genetics and genetic engineering; medical research; electronic data storage; design and development of computer software systems comprised of computer software platforms and computer software applications for data input, output, processing, display and storage

Downloadable software for word processing in the field of medicine, healthcare, genetics, foods and dietary supplements; Downloadable computer software for database management; Scientific instruments and laboratory research apparatus for the determination of DNA sequence, RNA transcript and protein sequence, namely DNA or RNA sequencing instruments for long-read genome sequencing, short-read targeted genome sequencing and whole genome sequencing for analysis of biomolecules in multi-modal biomarker discovery, genomics, proteomics and epigenetic biomarkers and validation scientific research studies, for identification of biomolecules in scientific research and related to multi-factorial analysis of scientific data, and for detection of scientific data, namely, biomedical data by use of semantic discovery engines used by biomedical researchers; Scientific instruments and laboratory research apparatus for the determination of DNA sequence, RNA transcript and protein sequence, namely instruments for sequencing by synthesis, exome, transcriptome sequencing and epigenetic profiling for analysis of biomolecules in multi-modal biomarker discovery, genomics, proteomics and epigenetic biomarkers and validation scientific research studies, for identification of biomolecules in scientific research and related to multi-factorial analysis of scientific data, and for detection of scientific data, namely, biomedical data by use of semantic discovery engines used by biomedical researchers; Scientific instruments and laboratory research apparatus, namely instruments for DNA methylation sequencing based on ChIP-Seq, methyl-seq, nano pore and epigenetic profiling for analysis of biomolecules in multi-modal biomarker discovery, genomics, proteomics and epigenetic biomarkers and validation scientific research studies, for identification of biomolecules in scientific research and related to multi-factorial analysis of scientific data, and for detection of scientific data, namely, biomedical data by use of semantic discovery engines used by biomedical researchers; Scientific instruments and laboratory research apparatus, namely DNA sequencing instruments for the determination of targeted/whole genome SNP genotypes and other genomic variants/rearrangements for analysis of biomolecules in multi-modal biomarker discovery, genomics, proteomics and epigenetic biomarkers and validation scientific research studies, for identification of biomolecules in scientific research and related to multi-factorial analysis of scientific data, and for detection of scientific data, namely, biomedical data by use of semantic discovery engines used by biomedical researchers; Scientific instruments and laboratory research apparatus, namely hybridization capture apparatus, including bead-based and fixed-array capture systems for pre-defined SNP genotyping for analysis of biomolecules in multi-modal biomarker discovery, genomics, proteomics and epigenetic biomarkers and validation scientific research studies, for identification of biomolecules in scientific research and related to multi-factorial analysis of scientific data, and for detection of scientific data, namely, biomedical data by use of semantic discovery engines used by biomedical researchers; Scientific instruments and laboratory research apparatus, namely protein sequencing and transcriptomic analysis instruments utilizing RNA sequencing-based readouts, immunoassay-based technologies, mass spectrometry (MALDI-TOF), Edman Degradation, high-performance liquid chromatography (HPLC) for analysis of biomolecules in multi-modal biomarker discovery, genomics, proteomics and epigenetic biomarkers and validation scientific research studies, for identification of biomolecules in scientific research and related to multi-factorial analysis of scientific data, and for detection of scientific data, namely, biomedical data by use of semantic discovery engines used by biomedical researchers; Scientific apparatus and instruments for analyzing DNA, RNA and protein using a downloadable computer software analytics platform for analysis of scientific data; electronic data carriers containing data in the nature of stored typographic typefaces; Computers

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 24, 2026 NPUB
PUBLISHED FOR OPPOSITION
Feb 24, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 18, 2026 NONP
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Jan 23, 2026 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 16, 2026 CNSA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jan 15, 2026 ZZZX
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Dec 19, 2025 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 8, 2025 CNSA
ASSIGNED TO EXAMINER
Nov 10, 2025 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 6, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 6, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 6, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 7, 2025 GNRN
NON-FINAL ACTION E-MAILED
Aug 7, 2025 GNRT
NON-FINAL ACTION WRITTEN
Aug 7, 2025 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 11, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 11, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 11, 2025 TROA
NOTICE OF REVIVAL - E-MAILED
Jul 11, 2025 NREV
PETITION TO REVIVE-GRANTED
Jul 11, 2025 PETG
TEAS PETITION TO REVIVE RECEIVED
Jul 11, 2025 PROA
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jun 16, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jun 16, 2025 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 28, 2025 GNRN
NON-FINAL ACTION E-MAILED
Feb 28, 2025 GNRT
NON-FINAL ACTION WRITTEN
Feb 28, 2025 CNRT
ASSIGNED TO EXAMINER
Feb 10, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 16, 2025 NWOS
NEW APPLICATION ENTERED
Aug 2, 2024 NWAP